310 related articles for article (PubMed ID: 21029352)
1. Stability and tolerability of high concentrations of intrathecal bupivacaine and opioid mixtures in chronic noncancer pain: an open-label pilot study.
Goucke CR; Dusci LJ; Van Leeuwen S; Fairclough D; Ilett KF
Pain Med; 2010 Nov; 11(11):1612-8. PubMed ID: 21029352
[TBL] [Abstract][Full Text] [Related]
2. Stability and compatibility of drug mixtures in an implantable infusion system.
Bianchi F; Ginggen A; Tardy Y
Anaesthesia; 2008 Sep; 63(9):972-8. PubMed ID: 18699872
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal therapy-associated masses.
Meta G; Ghaleb A; Gentry WB; Firnhaber J
Anesth Analg; 2006 Jul; 103(1):260-1. PubMed ID: 16790677
[No Abstract] [Full Text] [Related]
4. [Intrathecal administration of morphine and bupivacaine in the treatment of severe pain in chronic pancreatitis].
Verheijen R; Slappendel R; Jansen JB; Crul BJ; van Dongen RT
Ned Tijdschr Geneeskd; 1996 Jul; 140(27):1410-2. PubMed ID: 8766685
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal drug delivery for the management of cancer pain: a multidisciplinary consensus of best clinical practices.
Stearns L; Boortz-Marx R; Du Pen S; Friehs G; Gordon M; Halyard M; Herbst L; Kiser J
J Support Oncol; 2005; 3(6):399-408. PubMed ID: 16350425
[TBL] [Abstract][Full Text] [Related]
6. Postoperative continuous intrathecal pain treatment in children after selective dorsal rhizotomy with bupivacaine and two different morphine doses.
Hesselgard K; Strömblad LG; Romner B; Reinstrup P
Paediatr Anaesth; 2006 Apr; 16(4):436-43. PubMed ID: 16618299
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of severe cancer pain via spinal catheters].
Andersen JS; Markers PI; Valentin N
Ugeskr Laeger; 1996 Nov; 158(46):6613-6. PubMed ID: 8966828
[TBL] [Abstract][Full Text] [Related]
8. Priapism--a rare complication following continuous epidural morphine and bupivacaine infusion.
Ruan X; Couch JP; Shah RV; Liu H; Wang F; Chiravuri S
Pain Physician; 2007 Sep; 10(5):707-11. PubMed ID: 17876369
[TBL] [Abstract][Full Text] [Related]
9. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
10. Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system.
Hildebrand KR; Elsberry DD; Deer TR
Clin J Pain; 2001 Sep; 17(3):239-44. PubMed ID: 11587115
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal hydromorphone for intractable nonmalignant pain: a retrospective study.
Du Pen S; Du Pen A; Hillyer J
Pain Med; 2006; 7(1):10-5. PubMed ID: 16533191
[TBL] [Abstract][Full Text] [Related]
12. Preliminary study of the plasma and cerebrospinal fluid concentrations of IL-6 and IL-10 in patients with chronic pain receiving intrathecal opioid infusions by chronically implanted pump for pain management.
Zin CS; Nissen LM; O'Callaghan JP; Moore BJ; Smith MT
Pain Med; 2010 Apr; 11(4):550-61. PubMed ID: 20202139
[TBL] [Abstract][Full Text] [Related]
13. Plasma levels of bupivacaine and its metabolites after subacromial infusions in concentrations 2.5 or 5.0 mg/ml.
Merivirta RM; Kuusniemi KS; Hurme SA; Neuvonen PJ; Rautakorpi PJ; Olkkola KT; Leino KA
Acta Anaesthesiol Scand; 2011 Feb; 55(2):228-33. PubMed ID: 21039358
[TBL] [Abstract][Full Text] [Related]
14. Improving the analgesic efficacy of intrathecal morphine with parecoxib after total abdominal hysterectomy.
Niruthisard S; Werawataganon T; Bunburaphong P; Ussawanophakiat M; Wongsakornchaikul C; Toleb K
Anesth Analg; 2007 Sep; 105(3):822-4. PubMed ID: 17717245
[TBL] [Abstract][Full Text] [Related]
15. Long-term intrathecal morphine and bupivacaine upregulate MOR gene expression in lymphocytes.
Campana G; Sarti D; Spampinato S; Raffaeli W
Int Immunopharmacol; 2010 Sep; 10(9):1149-52. PubMed ID: 20609402
[TBL] [Abstract][Full Text] [Related]
16. Addition of low-dose morphine to intrathecal bupivacaine/sufentanil labour analgesia: A randomised controlled study.
Hein A; Rösblad P; Norman M; Ryniak S; Tingåker B; Jakobsson J; Dahlgren G
Int J Obstet Anesth; 2010 Oct; 19(4):384-9. PubMed ID: 20813517
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal addition of morphine to bupivacaine.
Borgeat A; Stirnemann HR
Reg Anesth Pain Med; 1999; 24(1):94-5. PubMed ID: 9952102
[No Abstract] [Full Text] [Related]
18. Epidural analgesia compared with intravenous analgesia after pediatric posterior spinal fusion.
Gauger VT; Voepel-Lewis TD; Burke CN; Kostrzewa AJ; Caird MS; Wagner DS; Farley FA
J Pediatr Orthop; 2009 Sep; 29(6):588-93. PubMed ID: 19700988
[TBL] [Abstract][Full Text] [Related]
19. 0.1% bupivacaine does not reduce the requirement for epidural fentanyl infusion after major abdominal surgery.
Salomäki TE; Laitinen JO; Vainionpää V; Nuutinen LS
Reg Anesth; 1995; 20(5):435-43. PubMed ID: 8519722
[TBL] [Abstract][Full Text] [Related]
20. Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients.
Veizi IE; Hayek SM; Narouze S; Pope JE; Mekhail N
Pain Med; 2011 Oct; 12(10):1481-9. PubMed ID: 21943351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
